Sonali Narain, MD
Rheumatology Physician in Great Neck, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,200 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Sonali Narain, MD reported a CMS MIPS final score of 91.3/100 - above the 83.5 national average - and filed 859 Medicare Part D claims in 2023.
- 91.3/100
- MIPS score · +8 vs avg
- 859
- Part D claims, 2023
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1124250287 · Rheumatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1124250287
- ENUM-MID 2009
- TAX-MID 6K Rheumatology Physician
- MIPS-ABOVE 91.3/100
- RX-LIGHT 859
- BOOK-THIN 456 in New York
- PHOTO-FINISH Ivana Ilic · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Narain · this pr…
Narain · this provider
91.3 MIPS pts
- Kyle Park · high…
Kyle Park
91.3 MIPS pts
- Ivana Ilic · near
Ivana Ilic
91.3 MIPS pts
- Hamead Moshrefi …
Hamead Moshrefi
91.3 MIPS pts
- Jonathan Paramo …
Jonathan Paramo
91.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Sonali Narain, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sonali Narain, MD sits
This provider among rheumatology physician peers
Across the 1,970 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sonali Narain, MD writes more Part D claims than 23% of them and scores higher on MIPS quality than 60% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Sonali Narain, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Sonali Narain, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sonali Narain, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Rheumatology Physician compares to other specialties among New York providers
Rheumatology Physician ranks #106 among New York's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Sonali Narain, MD's 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 91.3/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Rheumatology Physician US NPIs
91.3/100 MIPS final score - 7.8 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Rheumatology Physician. Quality dim: 74.9.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1124250287 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 08/21/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Sonali Narain, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1124250287 is the unique 10-digit identifier CMS uses to link Narain across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Sonali Narain, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sonali Narain, MD. Source: openpaymentsdata.cms.gov.
Total received
$8.6K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Sonali Narain, MD. To verify Sonali Narain, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 859 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,253
- Total Day Supply
- 35,726
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $889K
- Generic Drug Cost
- $38K
- Antibiotic Claims
- 38
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 24, 65-74: 69, 75-84: 37, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sonali Narain, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
121 claims
- Methotrexate
Methotrexate
78 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
66 claims
- Alendronate Sodium
Alendronate Sodium
55 claims
- Mycophenolate Mofe… 46
Mycophenolate Mofetil
46 claims
- Gabapentin 37
Gabapentin
37 claims
- Allopurinol 33
Allopurinol
33 claims
- Duloxetine Hcl 33
Duloxetine Hcl
33 claims
| Drug | Claims |
|---|---|
| Prednisone | 121 |
| Methotrexate Methotrexate Sodium | 78 |
| Hydroxychloroquine Sulfate | 66 |
| Alendronate Sodium | 55 |
| Mycophenolate Mofetil | 46 |
| Gabapentin | 37 |
| Allopurinol | 33 |
| Duloxetine Hcl | 33 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 32 |
| Leflunomide | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Sonali Narain, MD fits within the Rheumatology Physician landscape nationally.
Sonali Narain, MD's 859 claims are below the specialty average of 2,054.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Narain, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.3 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Narain.
One of 456 Rheumatology Physician providers enrolled in New York, 5 are shown here.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sonali Narain, MD's specialty? ▼
How much does Sonali Narain, MD prescribe under Medicare Part D? ▼
What is Sonali Narain, MD's Medicare quality score? ▼
Where is Sonali Narain, MD located? ▼
What is Sonali Narain, MD's NPI number? ▼
Does Sonali Narain, MD prescribe more brand-name or generic drugs? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Sonali Narain, MD prescribe most often? ▼
Does Sonali Narain, MD accept Medicare? ▼
How can I verify Sonali Narain, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.